Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net loss	$ (1,725)	$ (6,660)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Amortization of debt discount and issuance cost	1,645	1,473
Bad debt expense (recovery)	9	(114)
(Gain) loss on settlement of liabilities	(856)	2,992
Changes in deferred tax assets and liabilities	(654)	912
Change in allowance for sales returns and volume rebate	431	542
Change in inventory reserve	634	56
Change in fair value of derivative liability	(1,537)	164
Shares issued for interest payment on notes payable		512
Stock compensation expense	2,665	3,020
Depreciation and amortization	6,818	5,264
Non-cash lease expense	(20)
Changes in operating assets and liabilities:
Accounts receivable - trade	(26,240)	(26,658)
Inventories	(4,722)	(10,084)
Prepaid expenses and other assets	(41)	(8,375)
Other assets	(332)
Accounts payable and accrued expenses	21,592	17,865
Other liabilities	(1,737)	2,134
Deferred revenues	4,570	3,875
Net cash provided by (used in) operating activities	500	(13,082)
Cash flows from investing activities:
Business acquisitions (net of cash acquired)		(804)
Asset acquisition	(100)
Purchases of property and equipment, net	(960)	(139)
Net cash used in investing activities	(1,060)	(943)
Cash flows from financing activities:
Net proceeds from issuance of common stock and warrants, net of issuance costs	4,700	405
Proceeds from issuances of short-term debt	2,500	43,269
Proceeds from exercise of options and warrants	70
Principal payments on debt	(1,878)	(35,487)
Debt issuance costs		(70)
Payments of fixed dividends to Series B Preferred stockholders	(952)	(952)
Net cash provided by financing activities	4,440	7,165
Effect of foreign currency exchange rates	134	(377)
Net increase (decrease) in cash and cash equivalents	4,014	(7,237)
Cash and cash equivalents, beginning of the period	17,938	13,460
Cash and cash equivalents, end of the period	21,952	6,223
Supplemental cash flow disclosures:
Cash paid for income taxes	1,615	1,458
Cash paid for interest	7,346	2,130
Non-cash investing and financing transactions:
Shares issued to settle accounts payable		1,626
Exercise of warrants		203
Deemed contribution - Series B Preferred		367
Deferred consideration for acquisition		537
Shares issued to convert notes payable and accrued interest		13,786
Shares issued for asset acquisition	$ 150	$ 403